|
| Investors |
|
| |
|
VIMAC Milestone Medica Fund
VIMAC Milestone Medica Fund is an early stage life sciences fund co-sponsored by VIMAC Ventures LLC, RBC Technology Ventures, and BTG. The Boston-based fund is focused on companies along the East Coast of the U.S. and into Ontario and Quebec. Joining the co-sponsors are a number of institutional investors including The Solidarity Fund QFL, headquartered in Montreal, with more than C$6.2 billion in assets, and other leading Montreal institutions. As a result of the strong support of these LPs, VMM has a unique focus on the Quebec life sciences community. More information about VIMAC is available at www.vimac.com. |
| |
| |
|
iNovia Capital
About iNovia Capital
iNovia provides venture capital to entrepreneurs who transform innovations into successful companies. The team is comprised of sector experts focused on Mobile, Consumer Internet, Internet Communications, Software and Digital Media. iNovia has $165M under management across two seed and early stage IT and Life Sciences funds. For more information, visit www.inoviacapital.com or follow iNovia on Twitter at http://twitter.com/iNovia.
|
| |
| |
|
MSBi Valorisation
MSBi Valorisation (“MSBiV”) is dedicated to commercializing seed stage innovations in information technology, life sciences and the physical sciences, that are based on technological advancements and inventions originating from McGill University, Université de Sherbrooke and Bishop's University, as well as their affiliated hospitals and research institutes. MSBiV focuses on establishing and building companies, as well as developing high potential licensing opportunities for its partner institutions. For more information see www.msbiv.ca. |
| |
| |
|
Medwell Capital Corporation
Medwell Capital Corp. is a Canadian-based leader in healthcare and leverages its expertise in clinical development, regulatory process, capital markets and due diligence to maximize shareholder value. The Company is organized into three separate business units:
Medwell Investments which manages the $40 million assets under management. Medwell Consulting whereby it performs internal pharma-level diligence analysis in support of investments, and provides clinical, advisory, regulatory and consulting services to companies. Medwell Securities supports Medwell’s investment model by identifying investment opportunities and advises companies in their financing, licensing and M&A strategies.
Medwell Capital evaluates numerous opportunities that could potentially benefit from its access to capital resources, banking and transaction experience, and technology assessment and management expertise. This provides an opportunity for Medwell Capital to directly invest in and support management with its expertise, as well as to provide merchant banking financing and advisory assistance. |
| |
|
|
| 
|
1000 de La Gauchetière Street West, Suite 900. Montréal, Québec, H3B 5H4, Canada
|
|
|
|
|
 hi-rez.jpg)
 logo (srgb) hirez.jpg)
